Volume 23, Number 8—August 2017
Research Letter
Outcomes for 2 Children after Peripartum Acquisition of Zika Virus Infection, French Polynesia, 2013–2014
Table
Follow-up of liver function test results associated with perinatal Zika virus infection in case-patient 2, French Polynesia, 2014*
Date (postnatal day) | AST, U/L† | ALT, U/L‡ | GGT, U/L§ | Bilirubin, total/conjugate, mg/L¶ |
---|---|---|---|---|
Feb 4 (2) | 84 | 11 | 201 | 158 |
Feb 6 (4) | 38 | 12 | 297 | 145 |
Feb 10 (8) | 52 | 18 | 457 | 128/21 |
Apr 8 (57) | 348 | 150 | 281 | 66/54 |
Apr 16 (65) | 239 | 139 | 312 | 50/42 |
Apr 30 (79) | 117 | 86 | 239 | 10 |
May 13 (92) | 119 | 104 | 164 | 8 |
Jun 17 (120) | 57 | 51 | 40 | 2 |
Oct 25 (250) | 38 | 47 | 27 | 2 |
*Boldface indicates values out of reference range. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase.
†Reference range 15–40 U/L.
‡Reference range 10–40 U/L.
§Reference range 2–34 U/L.
¶Reference range <14/<3 mg/L.